Edition:
India

People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,334.95INR
22 Jun 2018
Change (% chg)

Rs18.30 (+0.79%)
Prev Close
Rs2,316.65
Open
Rs2,317.00
Day's High
Rs2,346.45
Day's Low
Rs2,275.25
Volume
172,206
Avg. Vol
87,223
52-wk High
Rs2,788.00
52-wk Low
Rs1,888.00

Reddy, Cartikeya 

Dr. Cartikeya Reddy serves as an Executive Vice President and Head-Biologics of Dr. Reddy's Laboratories Ltd. He focuses on the development of biosimilar molecules for the Indian and global markets. Prior to joining in 2004, Mr. Reddy worked with Genentech Inc., where he was a Group Leader in the area of Cell Culture Process Development. Before that, he was with the Biotechnology Division of Bayer Corporation, where he led teams in the areas of Bioprocess Development and pilot scale manufacturing. Mr. Reddy holds a Master of Science degree and Ph.D. in Chemical Engineering from the University of Illinois, Urbana-Champaign, and was a Visiting Scholar at the Massachusetts Institute of Technology in Cambridge, Massachusetts, United States of America. He also graduated with a Bachelor of Technology degree in Chemical Engineering from the Indian Institute of Technology in Chennai, India.

Basic Compensation

Total Annual Compensation, INR --
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 8,800,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --